Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy

Completed

Conditions studied: Multiple Sclerosis

In brief

An observational study to determine the impact of multiple neutralizing antibody (NAb) tests on treatment patterns compared to the usual care of MS patients receiving high-dose IFN therapy.

Key facts

Study ID

NCT00336557

Run by

Teva Branded Pharmaceutical Products R&D, Inc.

People needed

1230

Starts

2006-07-01

Expected to finish

2009-07-01

Last updated by the study team

2013-10-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Willing to provide informed consent.
• Male or female, 18 years of age or older, with a diagnosis of MS.

You may not qualify if…

• Has been on oral or parenteral corticosteroid therapy within the two weeks prior to the Baseline Visit.
• Has been treated with immunoglobulins (IgG) or plasmapheresis within the last six months.
• Has any condition which the investigator or nurse feels may interfere with participation in the study or with assessments for the full duration of the study.
• Previously participated in this study.
• Has received an experimental drug in the last thirty (30) days.

Where it is running

• Phoenix Neurological Associates, LTD — Phoenix, Arizona, United States
• East Bay Physicians Medical Group — Berkley, California, United States
• Neuro-Pain Medical Center — Fresno, California, United States
• Fullerton Neurology and Headache Center — Fullerton, California, United States
• University of Southern California — Los Angeles, California, United States
• University of California, Davis — Sacramento, California, United States
• Neurology Clinic of Marin — San Anselmo, California, United States
• Colorado Springs Neurological Associates, PC — Colorado Springs, Colorado, United States
• Colorado Neurosurgery — Engelwood, Colorado, United States
• The Emery Neuroscience Center — Fort Lauderdale, Florida, United States
• Neurology Associates, PA — Maitland, Florida, United States
• Collier Neurologic Specialitsts — Naples, Florida, United States
• Axiom Clinical Research of Florida — Tampa, Florida, United States
• University of South Florida — Tampa, Florida, United States
• Medical College of Georgia Augusta MS Center — Augusta, Georgia, United States
• Carle Clinic Association — Urbana, Illinois, United States
• Neurology Associates — Hopedale, Massachusetts, United States
• Lahey Clinic — Lexinton, Massachusetts, United States
• South Shores Neurology Associates, INC — South Weymouth, Massachusetts, United States
• Michigan Neurology Associates — Saint Clair Shores, Michigan, United States
• Mankato Clinic — Mankato, Minnesota, United States
• Columbia Center for Neurology and MS — Columbia, Missouri, United States
• St John's Mercy Medical Center — St Louis, Missouri, United States
• Advanced Neurology Specialist — Great Falls, Montana, United States
• Creighton University Department of Neurology — Bellvue, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.